; (B) reproductive or sexual health conditions, status, diseases, or diagnoses, including pregnancy and pregnancy-related conditions, menstruation, ovulation, ability to conceive a pregnancy, whether such individual is sexually active, and whether such individual is engaging in unprotected sex; (C) reproductive- and sexual-health-related surgeries or procedures, including abortion; (D) use or purchase of contraceptives, medication abortion, or any other drug, device, or materials related to reproductive health; (E) bodily functions, vital signs, measurement, or symptoms related to menstruation or pregnancy, such as basal temperature, cramps, bodily discharge, or hormone levels; (F) any information about diagnoses or diagnostic testing, treatment, medications, or the purchase or use of any product or service relating to the matters described in subparagraphs (A) through (E); and (G) any information described in subparagraphs (A) through (F) that is derived or extrapolated from non-health information, including proxy, derivative, inferred, emergent, and algorithmic data. (6) Regulated entity (A) In general The term regulated entity means any entity (to the extent such entity is engaged in activities in or affecting commerce (as defined in section 4 of the Federal Trade Commission Act ( 15 U.S.C. 44 ))) that is— (i) a person, partnership, or corporation subject to the jurisdiction of the Commission under section 5(a)(2) of the Federal Trade Commission Act ( 15 U.S.C. 45(a)(2) ); or (ii) notwithstanding section 4, 5(a)(2), or 6 of the Federal Trade Commission Act ( 15 U.S.C. 44 ; 45(a)(2); 46) or any jurisdictional limitation of the Commission— (I) a common carrier subject to the Communications Act of 1934 ( 47 U.S.C. 151 et seq. ) and all Acts amendatory thereof and supplementary thereto